HK1066027A1 - Bacillus anthracis strain. - Google Patents

Bacillus anthracis strain.

Info

Publication number
HK1066027A1
HK1066027A1 HK04108982A HK04108982A HK1066027A1 HK 1066027 A1 HK1066027 A1 HK 1066027A1 HK 04108982 A HK04108982 A HK 04108982A HK 04108982 A HK04108982 A HK 04108982A HK 1066027 A1 HK1066027 A1 HK 1066027A1
Authority
HK
Hong Kong
Prior art keywords
bacillus anthracis
anthracis strain
strain
bacillus
anthracis
Prior art date
Application number
HK04108982A
Other languages
English (en)
Inventor
Michele Mock
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of HK1066027A1 publication Critical patent/HK1066027A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK04108982A 1999-09-10 2004-11-13 Bacillus anthracis strain. HK1066027A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9911384A FR2798291B1 (fr) 1999-09-10 1999-09-10 Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis

Publications (1)

Publication Number Publication Date
HK1066027A1 true HK1066027A1 (en) 2005-03-11

Family

ID=9549750

Family Applications (3)

Application Number Title Priority Date Filing Date
HK04108982A HK1066027A1 (en) 1999-09-10 2004-11-13 Bacillus anthracis strain.
HK05101248A HK1068100A1 (en) 1999-09-10 2005-02-16 Bacillus anthracis exoantigens.
HK05101310A HK1068502A1 (en) 1999-09-10 2005-02-16 Passive immunisation against bacillus anthracis.

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK05101248A HK1068100A1 (en) 1999-09-10 2005-02-16 Bacillus anthracis exoantigens.
HK05101310A HK1068502A1 (en) 1999-09-10 2005-02-16 Passive immunisation against bacillus anthracis.

Country Status (6)

Country Link
US (3) US6979449B1 (fr)
CA (1) CA2384437C (fr)
FR (1) FR2798291B1 (fr)
GB (1) GB2370772B (fr)
HK (3) HK1066027A1 (fr)
WO (1) WO2001019395A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958960A3 (fr) * 2001-12-05 2009-01-07 Rakesh Bhatnagar Processus pour la préparation d'un vaccin d'anthrax non toxique
US20030118591A1 (en) * 2001-12-21 2003-06-26 Joshua Levy Passive hyperimmune antibody therapy in the treatment of anthrax
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
US7504425B2 (en) * 2002-05-29 2009-03-17 Merck & Co., Inc. Compounds useful in the treatment of anthrax and inhibiting lethal factor
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
US20070154494A1 (en) * 2003-02-13 2007-07-05 Becton Dickinson And Company Anthrax vaccines and delivery methods
US8409590B2 (en) 2004-02-11 2013-04-02 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
AU2005250351A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
WO2006044728A2 (fr) * 2004-10-18 2006-04-27 U.S.Genomics, Inc. Procedes d'isolation d'acides nucleiques de spores procaryotiques
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
EP1954307A4 (fr) * 2005-11-14 2009-12-02 Univ Maryland Biotech Inst Vaccins oraux a base de salmonelle contre l'anthrax
CA2651962A1 (fr) 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Compositions contre l'anthrax et procedes d'utilisation et de production de celles-ci
GB0916570D0 (en) * 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
MX347611B (es) 2011-06-19 2017-05-04 Abogen Inc Dispositivos, soluciones y metodos para recoleccion de muestras.
JP2017516477A (ja) * 2014-05-27 2017-06-22 ディーエヌエー ジェノテック インク 頑丈な微生物の生存能力を安定化および維持するための組成物および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676068B1 (fr) * 1991-05-02 1994-11-04 Pasteur Institut Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
RU2115433C1 (ru) * 1992-08-28 1998-07-20 Научно-исследовательский институт микробиологии МО РФ Вакцина сибиреязвенная комбинированная
EP0739981A1 (fr) * 1995-04-25 1996-10-30 Vrije Universiteit Brussel Fragments variables d'immunoglobulines-utilisation thérapeutique ou vétérinaire

Also Published As

Publication number Publication date
GB2370772B (en) 2004-09-01
FR2798291A1 (fr) 2001-03-16
HK1068502A1 (en) 2005-04-22
US20060099228A1 (en) 2006-05-11
US20090110700A1 (en) 2009-04-30
FR2798291B1 (fr) 2005-01-14
US6979449B1 (en) 2005-12-27
CA2384437A1 (fr) 2001-03-22
GB0207118D0 (en) 2002-05-08
GB2370772A (en) 2002-07-10
US7491404B2 (en) 2009-02-17
HK1068100A1 (en) 2005-04-22
CA2384437C (fr) 2012-09-04
WO2001019395A1 (fr) 2001-03-22

Similar Documents

Publication Publication Date Title
HK1068100A1 (en) Bacillus anthracis exoantigens.
HK1037453A1 (en) Earphone.
HK1052037A1 (en) Structural member.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200001665B (en) Suspension device.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1042488A1 (en) 1-Heterocycle substituted diarylamines.
HK1035567A1 (en) Buffer device.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200210206B (en) Expression system.
ZA200107898B (en) Dispersion compensating fiber.
ZA200202537B (en) Pour-on-formulations.
ZA200201518B (en) Dispersion formulations containing lipase inhibitors.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
AU3305800A (en) Strain sensing
MXPA02000261A (es) Aminoindanos novedosos.
AU2001276768A1 (en) Touch pad system
ZA992018B (en) Banners.
AU2002227055A1 (en) Bacterial strain typing
ZA200107740B (en) Adjusting device.
MXPA01010701A (es) Vacuna.
GB2398242B (en) Bacillus anthracis strain
EP1231266A4 (fr) Gene de la gdp-4-keto-6-desoxy-d-manose-3,5-epimerase-4-reductase tire de l'arabidopsis
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120908